ArticleCancer immunology, immunotherapy : CII2009

HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.